How are you incorporating immune checkpoint inhibitors in the treatment of relapsed Hodgkin lymphoma?  

Are you routinely incorporating in 2L salvage chemotherapy for transplant eligible patients? Or reserving for later lines of therapy or in those transplant ineligible?